Denosumab China Phase III Study

Clinical trial NCT02014467 · COMPLETED

Trial details

NCT number: NCT02014467
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2014-01-01
Primary completion: 2015-08-01
Enrollment: 486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.